Kura Oncology (KURA) Gross Margin Growth (1y) (2026)

Kura Oncology (KURA) Gross Margin Growth (1y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -93.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -91.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 236.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 228.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 6.06 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -475.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 1,034.00
10 Kura Oncology 966.11 Mn 966.11 Mn 20.63 Mn -116.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -116.00
Mar 31, 2026 -143.00